From Prenatal Testing to Oncology: Noninvasive Technology Advances

Ajouter une nouvelle offre d'emploi Health

2025-06-20 09:35:17

The Noninvasive Cancer Diagnostics Market, valued at approximately USD 5.8 billion in 2024, is projected to reach around USD 15.3 billion by 2031, representing a robust 16.2% compound annual growth rate through 2025–2031. This surge is fueled by technological advances in liquid biopsies, AI enabled imaging, and an increasing volume of early cancer screening across clinical channels....

0 Commentaires 0 Parts 79 Vue 0 Aperçu